ReviewFrontiers in immunology2022

Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature review.

Yunpeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.